with pain. The term opioids has replaced the term opiates, which refers specifically to the products derived from the juice of the opium poppy (Papaver somniferum). Opioid refers to any directly-acting compound whose effects are reversed by the specific opioid antagonistnaloxone (Hughes & Kosterlitz 1983) .
Clinical evidence would suggest that morphine and other opioids are more effective at controlling second pain, that is pain mediated by small c-fibres, than first pain mediated by the A-delta fibres. The classic example is of the patient who having received morphine will feel a pin prick as normal, although it may be less unpleasant. Such findings would suggest that morphine and related analgesics act in that part of the central nervous system involved in the transmission of second pain. Information of this type led to the isolation of specific opioid receptors or binding sites on neurons in the substantia gelatinosa, the spinal nucleus of the V nerve and, to a lesser extent, in the intralaminar thalamic nucleus (Pert & Snyder 1973) . Anatomically all these areas are related to second pain transmission.
Opioid receptors There are at least three distinct opioid receptors, designated mu (,u), kappa (K) and delta (b) (Paterson et al. 1983) . Stimulation of each of these receptors produces the responses shown in Table 1 . There may well be marked inter-individual variation of opioid receptor populations, which may account for differences in response to morphine and related drugs. Morphine acts primarily on the 4u receptor, whereas benzomorphan derivatives such as pentazocine interact with both K and 6 receptors.
The identification of opioid receptors led to speculation that man may possess an endogenous opioid system which could play an important role in the suppression of pain. In 1975, Hughes et al. identified an endogenous ligand for the opioid receptors, referred to as enkephalin. Since then many endogenous peptides have been isolated which include the pentapeptidesmethioninenkephalin and leucinenkephalin, peptide E, dynorphin, aneoendorphin, fi-neoendorphin, f,-endorphin and the related a-, y-, and 6-endorphins. All these peptides are collectively referred to as the opioid peptides. Experimental evidence would suggest that the .opioid peptides serve as chemical messengers, either neurotransmitters, hormones or neurohormones, in an extensive and complex inhibitory signalling system in which the selectivity of a messenger is achieved by the use of a combination of specific opioid peptides and receptors.
Opioid peptides and pain transmission
The role of the opioid peptides in the transmission of pain is not clearly established. A likely mechanism appears to be the interaction between substance P and methioninenkephalin (Jessel & Iversen 1977) . Substance P is a neurotransmitter for small fibre afferents in the substantia gelatinosa (Hokfelt et al. 1975 ). Synapsing with the small fibre terminal is an interneurone, whose neurotransmitter is methioninenkephalin. Activity within this enkephalinergic fibre is under the control of the cortex via the nucleus raphe magnus. When methioninenkephalin is released it will activate opioid receptors on the c-fibre terminal. Activation of the opioid receptors causes depolarization of the cell membrane which, in turn, prevents the release of substance P. The nerve impulse conveying painful information does not progress beyond the synapse.
In addition to the pain-suppressing system brought about by activity in enkephalinergic fibres, activity in large sensory A-beta fibres can cause presynaptic inhibition and Postoperative dental pain and analgesic efficacy Pain arising from a dental surgical procedure often requires treatment with an analgesic ). Pain following removal of an impacted lower third molar has been extensively studied and used to evaluate analgesic efficacy (Seymour & Walton 1982) . Previous studies (Lokken et al. 1975 , Album et al. 1977 have shown that patients who require removal of their bilaterally-impacted lower third molars ( Figure 1 ) provide a suitable model for testing analgesics. When these teeth are removed under local anaesthetic nerve block by the same surgeon, a similar operation is performed on two separate occasions. Since the amount of operative trauma and postoperative pain is broadly comparable on each occasion, the patients can act as their own controls in a crossover trial comparing analgesic with placebo. The Lokken model has been used to evaluate analgesic efficacy over a threeor five-day postoperative period. Cooper & Beaver (1976) have similarly reported on the value of postoperative pain after third molar removal in testing for analgesic efficacy. Patients who have undergone removal of an impacted lower third molar usually experience their most severe pain in the first 12 hours after the operation (Chapnick et al. 1980 ) and the pain usually reaches its maximum intensity 6-8 hours postoperatively (Szmyd et al. 1965) . Pain intensity rapidly decreases and therefore the patient's pain is well suited for testing the efficacy of a single dose of analgesic in the immediate period following surgery.
A further modification of the third molar pain model was reported by Seymour & Rawlins (1981) , who used patients who had undergone removal of their bilaterally-similar impacted lower third molars to test the efficacy of a single dose of analgesic. This model combines the attributes of both the Lokken model, that is using patients as their own controls, and the Cooper & Beaver model, that is using the immediate postoperative period for testing the efficacy of a single dose of analgesic.
Peripherally-acting analgesics in postoperative dental pain Peripherally-acting analgesics, especially aspirin, have been extensively evaluated in postoperative dental pain, and many studies support the efficacy of these drugs ( 1982) . Over the past 3 years we have been investigating the efficacy and mechanism of action of aspirin in patients with pain after removal of their bilaterally-similar impacted lower third molars (Figure 1 ). In these studies patients had their bilaterally-similar impacted lower third molars removed under local anaesthesia (lignocaine 2%) on two separate occasions. In the immediate postoperative period the patients received either a single dose of drug, or an identical-tasting placebo. Each patient received both treatments in random double-blind order and thus acted as their own controls. The first study investigated the relationship between analgesia and plasma concentrations of aspirin and salicylate over a 5-hour period after 600 mg and 1200 mg soluble aspirin. After both doses of aspirin, patients reported less pain than after placebo. A significant difference from placebo (P <0.05) after 600 mg aspirin occurred only at 45 minutes after administration, whereas significant differences from placebo (P<0.05) occurred from 45 to 240 minutes after 1200 mg aspirin. The 1200 mg dose of aspirin not only provided greater analgesia than the 600 mg dose, but this was of longer duration. We also observed a significant correlation (r. = 0.87, P<0.01) between analgesia and plasma salicylate concentration after 1200 mg aspirin. However, the biological basis for this correlation was uncertain because the mechanism of aspirin-induced analgesia in postoperative pain was unclear. To try and explain this correlation, a further study (Seymour et al. 1984a ), using identical methodology, was carried out to evaluate the analgesic actions of sodium salicylate at equimolar dose to 600 mg and 1200 mg soluble aspirin (537 mg and 1074 mg sodium salicylate).
The results showed that patients' pain scores after both doses of sodium salicylate were practically identical to those after placebo, over the 5-hour investigation period. Therefore single doses of 537 mg and 1074 mg sodium salicylate have no analgesic action in postoperative pain after removal of impacted lower third molars. This finding has two important implications. Firstly, the correlation between plasma salicylate concentrations and analgesia after 1200 mg aspirin is clearly not causal. Secondly, although the mechanism of aspirin-induced analgesia in postoperative dental pain remains unclear, it has been suggested that the inhibition of cyclo-oxygenase by acetylation of the active site of the enzyme , Burch et al. 1978 ) plays a crucial role. The poor efficacy of sodium salicylate, as compared to aspirin, may thus be due to its weak inhibitory effect on the synthesis of prostaglandins E2 and F20 (Vane 1971) . However, aspirin and sodium salicylate are equipotent in inhibiting the formation of the leukotrienes 12-HETE from 12-HPETE in vitro (Siegel et al. 1979) . Our observation on the comparative analgesic efficacy of aspirin and sodium salicylate would therefore be compatible with the hypothesis that postoperative dental pain is primarily mediated by products of the cyclo-oxygenase pathway, and with little from the lipoxygenase products.
It would appear that the intact aspirin molecule (or the acetyl moiety) is essential for providing analgesia in postoperative dental pain. In vivo, aspirin is rapidly hydrolysed to salicylate by esterases (so-called aspirin esterases) (Menguy et al. 1972) . Previous findings have shown that aspirin is effective, whereas sodium salicylate is ineffective at reducing postoperative pain after third molar surgery. This evidence could perhaps suggest that plasma aspirin esterase activity may be an important determinant of aspirin's analgesic effect. In our third study (Seymour et al. 1984b) we investigated the relationship between plasma aspirin esterase activity, plasma aspirin concentrations and analgesic efficacy after aspirin 1200 mg in 15 patients who underwent removal of their bilaterally-similar impacted lower third molars.
Over the five-hour investigation period, patients reported significantly less pain (P<0.01) after treatment with aspirin than after treatment with placebo. Significant negative correlations were observed between plasma aspirin esterase activity and both total plasma concentration of aspirin (r = -0.904, P<0.001) and overall analgesic effect (r = -0.91, P < 0.001). Similarly, a significant correlation was observed between total plasma concentrations of aspirin and the overall analgesic effect (r = 0.96, P<0.001). Evidence from this study would suggest that an individual's pain relief in postoperative dental pain is determined by aspirin's hydrolysis to salicylate. Therefore, those patients who metabolize aspirin slowly, and hence have a low plasma aspirin esterase activity, obtain greater analgesia than those who metabolize the drug quickly.
Centrally-acting analgesics in postoperative dental pain By contrast to peripherally-acting analgesics, the efficacy of centrally-acting analgesics in postoperative dental pain is poor. Opioids such as codeine phosphate (Cooper & Beaver 1976 , Rondeau et al. 1980 , pentazocine (Ahlstrom et al. 1974 , Green 1976 ), dextropropoxyphene (Smith et al. 1975 ) and morphine (Hanks et al. 1980) have been shown to be no more effective than placebo in relieving postoperative dental pain.
Dihydrocodeine is the only opioid that has been evaluated in our pain model (Seymour et al. 1982 ) and the results were surprising. Twenty-four patients who had undergone bilateral third molar surgery received in random double-blind order either a single intravenous dose of dihydrocodeine (25 mg or 50 mg) or an identical placebo. After both doses of dihydrocodeine, patients reported significantly (P < 0.05) more pain than after placebo, with the hyperalgesia after dihydrocodeine 50 mg being greater than that after the 25 mg dose. We also reported, in this study, a significant correlation (P<0.01) between hyperalgesia and plasma concentrations of the major metabolite of dihydrocodeinedihydromorphine (Rowell et al. 1983 ).
The hyperalgesia produced by dihydrocodeine may, in part, be related to the drug's unwanted effects, which include nausea, drowsiness and 'grogginess'. These unwanted effects could cause general discomfort for the patient and may be reflected in their pain scores. The correlation between hyperalgesia and plasma concentration of dihydromorphine needs further investigation. It may be that dihydromorphine acts as an antagonist in man and causes displacement of the endogenous opioids. Such displacement could, theoretically, make the pain worse.
Why the efficacy of the opioids in postoperative dental pain is poor remains uncertain. It may be related to the poor peripheral action of the opioids in localized inflammatory pain. Alternatively, dental pain may have little involvement of the enkephalinergic system, the site of optimal opioid activity. Further studies are necessary to clarify these points.
Conclusions
Most types of dental pain have a localized inflammatory component, and analgesics with anti-inflammatory actions appear to be more effective than those which have only a central action.
